23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      D-serine as a gliotransmitter and its roles in brain development and disease

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The development of new techniques to study glial cells has revealed that they are active participants in the development of functional neuronal circuits. Calcium imaging studies demonstrate that glial cells actively sense and respond to neuronal activity. Glial cells can produce and release neurotransmitter-like molecules, referred to as gliotransmitters, that can in turn influence the activity of neurons and other glia. One putative gliotransmitter, D-serine is believed to be an endogenous co-agonist for synaptic N-methyl-D-aspartate receptors (NMDARs), modulating synaptic transmission and plasticity mediated by this receptor. The observation that D-serine levels in the mammalian brain increase during early development, suggests a possible role for this gliotransmitter in normal brain development and circuit refinement. In this review we will examine the data that D-serine and its associated enzyme serine racemase are developmentally regulated. We will consider the evidence that D-serine is actively released by glial cells and examine the studies that have implicated D-serine as a critical player involved in regulating NMDAR-mediated synaptic transmission and neuronal migration during development. Furthermore, we will consider how dysregulation of D-serine may play an important role in the etiology of neurological and psychiatric diseases.

          Related collections

          Most cited references137

          • Record: found
          • Abstract: not found
          • Article: not found

          Major depressive disorder.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Unraveling the mechanisms involved in motor neuron degeneration in ALS.

            Although Charcot described amyotrophic lateral sclerosis (ALS) more than 130 years ago, the mechanism underlying the characteristic selective degeneration and death of motor neurons in this common adult motor neuron disease has remained a mystery. There is no effective remedy for this progressive, fatal disorder. Modern genetics has now identified mutations in one gene [Cu/Zn superoxide dismutase (SOD1)] as a primary cause and implicated others [encoding neurofilaments, cytoplasmic dynein and its processivity factor dynactin, and vascular endothelial growth factor (VEGF)] as contributors to, or causes of, motor neuron diseases. These insights have enabled development of model systems to test hypotheses of disease mechanism and potential therapies. Along with errors in the handling of synaptic glutamate and the potential excitotoxic response this provokes, these model systems highlight the involvement of nonneuronal cells in disease progression and provide new therapeutic strategies.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.

              Many risk genes interact synergistically to produce schizophrenia and many neurotransmitter interactions have been implicated. We have developed a circuit-based framework for understanding gene and neurotransmitter interactions. NMDAR hypofunction has been implicated in schizophrenia because NMDAR antagonists reproduce symptoms of the disease. One action of antagonists is to reduce the excitation of fast-spiking interneurons, resulting in disinhibition of pyramidal cells. Overactive pyramidal cells, notably those in the hippocampus, can drive a hyperdopaminergic state that produces psychosis. Additional aspects of interneuron function can be understood in this framework, as follows. (i) In animal models, NMDAR antagonists reduce parvalbumin and GAD67, as found in schizophrenia. These changes produce further disinhibition and can be viewed as the aberrant response of a homeostatic system having a faulty activity sensor (the NMDAR). (ii) Disinhibition decreases the power of gamma oscillation and might thereby produce negative and cognitive symptoms. (iii) Nicotine enhances the output of interneurons, and might thereby contribute to its therapeutic effect in schizophrenia.
                Bookmark

                Author and article information

                Journal
                Front Cell Neurosci
                Front Cell Neurosci
                Front. Cell. Neurosci.
                Frontiers in Cellular Neuroscience
                Frontiers Media S.A.
                1662-5102
                23 April 2013
                2013
                : 7
                : 39
                Affiliations
                Montreal Neurological Institute, McGill University Montreal, QC, Canada
                Author notes

                Edited by: Keith Murai, McGill University, Canada

                Reviewed by: Carole Escartin, Molecular Imaging Research Center, France; Keith Murai, McGill University, Canada; Thomas Papouin, Tufts University School of Medicine, USA

                *Correspondence: Edward S. Ruthazer, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, QC, Canada H3A 2B4. e-mail: edward.ruthazer@ 123456mcgill.ca
                Article
                10.3389/fncel.2013.00039
                3632749
                23630460
                27ae79aa-e6d7-407d-9963-48e2338ab281
                Copyright © Van Horn, Sild and Ruthazer.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.

                History
                : 05 February 2013
                : 26 March 2013
                Page count
                Figures: 2, Tables: 0, Equations: 0, References: 159, Pages: 13, Words: 0
                Categories
                Neuroscience
                Review Article

                Neurosciences
                gliotransmission,d-serine,nmda receptors,schizophrenia,depression and anxiety disorders,neural development,glycine site,astrocyte–neuron interactions

                Comments

                Comment on this article